PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
27-Nov-2020 Interview Released with Robert Vries, CEO at Hubrecht Organoid Technology speaker at 3D Cell Culture SMi Group
25-Nov-2020 Celltrion completes enrolment for global Phase II clinical trial with COVID-19 treatment candidate CT-P59 Celltrion
20-Nov-2020 SMi’s 2nd Annual AI in Drug Discovery Announces key industry speakers and agenda released SMi Group
19-Nov-2020 COVID-19: Treatment for the Most Severely Affected Patients - After Promising Results in Named Patient Use - Clinical Trial with FX06 Starts in France F4 Pharma
19-Nov-2020 Medidata and Oxford University Innovation’s Clinical Outcomes Team Announce Addition of Gold Standard Questionnaires to eCOA Library Medidata
19-Nov-2020 One week to go Webinar on Cost-efficient and Green Manufacturing of Peptides thanks to Molecular Hiving™ Technology  SMi Group
18-Nov-2020 PureTech’s LYT-100 (Deupirfenidone) Demonstrates Tolerability and Pharmacokinetic Proof-of-Concept in Phase 1 Multiple Ascending Dose and Food Effect Study PureTech
18-Nov-2020 BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100 BioVersys
18-Nov-2020 PTC Therapeutics Announces that PTC518 Has Entered into a Phase 1 Clinical Trial for the Huntington’s Disease Program PTC Therapeutics
16-Nov-2020 SynDevRx Announces Positive Data from Phase 1 Safety Trial of SDX-7320 in Late Stage Cancer Patients SynDevRx
16-Nov-2020 AMZELL to initiate FDA-approved Phase 3 trial of innovative injectable treatment for infantile epileptic disease AMZELL B.V
16-Nov-2020 Q BioMed’s Uttroside-B Receives U.S. Patent in Treatment of Liver Cancer Q BioMed Inc
16-Nov-2020 Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering Envision Pharma Group
16-Nov-2020 Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer Myricx Pharma
16-Nov-2020 Bone Therapeutics announces completion of the acquisition of its cell therapy manufacturing subsidiary SCTS by Catalent Bone Therapeutics
16-Nov-2020 Calypso Biotech Announces Successful Dosing of First Phase 1 Cohort with Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 for the Treatment of Autoimmune Diseases Calypso Biotech
16-Nov-2020 Farxiga showed cardiovascular and renal benefit in patients with chronic kidney disease irrespective of cardiovascular disease status AstraZeneca 
16-Nov-2020 Full results from AFFIRM-AHF study show Ferinject® significantly reduces hospitalizations after acute heart failure in patients with iron deficiency Vifor Pharma
15-Nov-2020 Johnson & Johnson Initiates Second Global Phase 3 Clinical Trial of its Janssen COVID-19 Vaccine Candidate Johnson & Johnson
13-Nov-2020 AlzeCure receives approval to start clinical Phase I trial with ACD856 in Alzheimer's disease AlzeCure